Authors
- Benjamin Perry
![Author ORCID: We display the ORCID iD icon alongside authors names on our website to acknowledge that the ORCiD has been authenticated when entered by the user. To view the users ORCiD record click the icon. [opens in a new tab]](https://chemrxiv.org/engage/assets/public/chemrxiv/logo/orcid.png)
DNDi
, - yuichiro akao ,
- Stacie Canan ,
- Yafeng Cao ,
- Kevin Condroski ,
- Ola Engkvist ,
- sachiko itono ,
- rina kaki ,
- chiaki kimura ,
- Thierry Kogej ,
- Charles E. Mowbray ,
- kazuya nagaoka ,
- Akira Naito ,
- Hiromi Nakai ,
- Garry Pairaudeau ,
- Constantin Radu ,
- Ieuan Roberts ,
- mitsuyuki shimada ,
- David Shum ,
- Nao-aki Watanabe ,
- huanxu xie ,
- Shuji Yonezawa ,
- Osamu Yoshida ,
- Ryu Yoshida
Abstract
An
innovative pre-competitive virtual screening collaboration was engaged to
validate and subsequently explore an imidazo[1,2-a]pyridine screening hit for
visceral leishmaniasis. Parasitology and early ADME data is presented.
Version notes
v1 - submitted for peer review
Content
Supplementary material
SI 1 intro and assays final
SI 2 - Table of compounds final
SI 3 - experimental final
SI 4 - Analytical data final
